HomeNewsBusinessAnnouncementsGlenmark Pharma receives ANDA approval for Clobetasol Propionate Ointment

Glenmark Pharma receives ANDA approval for Clobetasol Propionate Ointment

Glenmark Pharmaceuticals Inc., USA has been granted final approval by the United States Food & Drug Administration (USFDA) for Clobetasol Propionate Ointment USP, 0.05 percent, the generic version of Temovate Ointment, 0.05 percent of Fougera Pharmaceuticals Inc.

March 21, 2017 / 09:32 IST
Story continues below Advertisement

Sub:- Glenmark Pharmaceuticals receives ANDA approval for Clobetasol Propionate Ointment USP, 0.05% With reference to the subject mentioned above, kindly find attached media release which is self-explanatory. Request you to kindly take the same on record.Source : BSE

Read all announcements in Glenmark

first published: Mar 21, 2017 09:32 am

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!